Trimethylammonium phenyl ketones. Actions on the cholinergic receptor and acetylcholinesterase.
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D002090:Butyrophenones / Q000138:chemical synthesis / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D002802:Cholinesterases / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006736:Horses; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007192:Indenes / Q000138:chemical synthesis / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010277:Parasympathomimetics / Q000138:chemical synthesis* / Q000494:pharmacology; D011427:Propiophenones / Q000138:chemical synthesis / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*; D013329:Structure-Activity Relationship
D002090:Butyrophenones; D002800:Cholinesterase Inhibitors; D007192:Indenes; D010277:Parasympathomimetics; D011427:Propiophenones; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D000110:Acetylcholinesterase; D002802:Cholinesterases